Real-time enrollment status for this cardiomyopathy clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 4:50 PM UTC
| NCT Number | NCT07052903 |
| Recruiting Status | Recruiting |
| Condition | Cardiomyopathy |
| Phase | PHASE3 |
| Target Enrollment | 1,750 participants |
| Active Locations | 45 sites in the US |
| Sponsor | Alnylam Pharmaceuticals |
| Last Updated on CT.gov | September 16, 2026 (Sep 16, 2026) |
As of October 18, 2026: Clinical trial NCT07052903 is currently recruiting participants. This phase3 study for cardiomyopathy is actively seeking new participants at 45 locations across the United States. The study is sponsored by Alnylam Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07052903 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 45 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07052903 was last updated Sep 16, 2026 (September 16, 2026). HelloStudys verifies this status automatically.